| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
|
Blood
|
2010
|
4.17
|
|
2
|
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
|
Lancet
|
2008
|
3.69
|
|
3
|
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
|
Blood
|
2003
|
1.80
|
|
4
|
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
|
Blood
|
2006
|
1.74
|
|
5
|
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
|
Blood
|
2013
|
1.67
|
|
6
|
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.
|
Proc Natl Acad Sci U S A
|
2004
|
1.53
|
|
7
|
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
|
J Clin Oncol
|
2010
|
1.47
|
|
8
|
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
|
Blood
|
2002
|
1.32
|
|
9
|
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
|
J Clin Oncol
|
2008
|
1.31
|
|
10
|
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
|
Haematologica
|
2004
|
1.29
|
|
11
|
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
|
Blood
|
2007
|
1.23
|
|
12
|
ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.
|
Blood
|
2011
|
1.21
|
|
13
|
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
|
Clin Cancer Res
|
2005
|
1.21
|
|
14
|
ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
|
Clin Cancer Res
|
2008
|
1.19
|
|
15
|
Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.
|
Haematologica
|
2012
|
1.18
|
|
16
|
Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips.
|
Clin Chem
|
2003
|
1.16
|
|
17
|
Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
|
Genes Chromosomes Cancer
|
2004
|
1.11
|
|
18
|
Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
|
Neoplasia
|
2005
|
1.08
|
|
19
|
Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis.
|
Blood
|
2002
|
1.08
|
|
20
|
Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).
|
Hematol J
|
2002
|
1.06
|
|
21
|
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.
|
Blood
|
2010
|
1.05
|
|
22
|
The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression.
|
PLoS One
|
2011
|
1.01
|
|
23
|
Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting.
|
Blood
|
2007
|
1.00
|
|
24
|
Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis.
|
Blood
|
2002
|
1.00
|
|
25
|
Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
|
Clin Cancer Res
|
2006
|
0.98
|
|
26
|
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
|
Br J Haematol
|
2012
|
0.95
|
|
27
|
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
|
Br J Haematol
|
2008
|
0.94
|
|
28
|
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
|
Haematologica
|
2007
|
0.93
|
|
29
|
Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants.
|
Genes Chromosomes Cancer
|
2006
|
0.93
|
|
30
|
Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
|
Br J Haematol
|
2007
|
0.93
|
|
31
|
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines.
|
Breast Cancer Res Treat
|
2003
|
0.92
|
|
32
|
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
|
Br J Haematol
|
2010
|
0.92
|
|
33
|
Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.
|
Blood
|
2012
|
0.91
|
|
34
|
The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21).
|
Oncogene
|
2003
|
0.90
|
|
35
|
Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
|
Br J Haematol
|
2009
|
0.88
|
|
36
|
Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases.
|
Genes Chromosomes Cancer
|
2006
|
0.87
|
|
37
|
Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
|
Haematologica
|
2005
|
0.87
|
|
38
|
Philadelphia chromosome-positive mature B-cell (Burkitt cell) leukaemia.
|
Br J Haematol
|
2002
|
0.86
|
|
39
|
Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32).
|
Oncogene
|
2004
|
0.84
|
|
40
|
Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.
|
Orphanet J Rare Dis
|
2006
|
0.84
|
|
41
|
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
|
Eur J Haematol
|
2010
|
0.84
|
|
42
|
Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
|
Genes Chromosomes Cancer
|
2003
|
0.84
|
|
43
|
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
|
Haematologica
|
2004
|
0.84
|
|
44
|
Acute monocytic leukaemia originating from MLL-MLLT3-positive pre-B cells.
|
Br J Haematol
|
2010
|
0.84
|
|
45
|
A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias.
|
Br J Haematol
|
2002
|
0.83
|
|
46
|
Evidence of a polyclonal nature of myositis ossificans.
|
Virchows Arch
|
2005
|
0.83
|
|
47
|
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
|
Biol Blood Marrow Transplant
|
2010
|
0.82
|
|
48
|
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.
|
Leuk Res
|
2006
|
0.81
|
|
49
|
Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones.
|
Cancer Genet Cytogenet
|
2003
|
0.80
|
|
50
|
Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
|
Blood
|
2007
|
0.80
|
|
51
|
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia.
|
Haematologica
|
2007
|
0.80
|
|
52
|
High-resolution analysis of alterations in medullary thyroid carcinoma genomes.
|
Int J Cancer
|
2011
|
0.80
|
|
53
|
Hypofibrinolysis, lipoprotein(a), and plasminogen activator inhibitor.
|
Clin Orthop Relat Res
|
2002
|
0.80
|
|
54
|
Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype.
|
Leuk Res
|
2004
|
0.79
|
|
55
|
NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
|
Clin Cancer Res
|
2005
|
0.79
|
|
56
|
Primary pigmented nodular adrenocortical disease (PPNAD) and pituitary adenoma in a boy with sporadic Carney complex due to a novel, de novo paternal PRKAR1A mutation (R96X).
|
J Pediatr Endocrinol Metab
|
2007
|
0.79
|
|
57
|
Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
|
J Allergy Clin Immunol
|
2007
|
0.79
|
|
58
|
DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.
|
Hum Mutat
|
2003
|
0.79
|
|
59
|
Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription.
|
Immunogenetics
|
2003
|
0.79
|
|
60
|
The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
|
Thyroid
|
2008
|
0.79
|
|
61
|
Equal frequency of TEL/AML1 rearrangements in children with acute lymphoblastic leukemia with and without Down syndrome.
|
Pediatr Hematol Oncol
|
2005
|
0.79
|
|
62
|
Clonality assessment in a case of multifocal adamantinoma and a review of the literature.
|
Case Rep Med
|
2012
|
0.78
|
|
63
|
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.
|
Leuk Lymphoma
|
2004
|
0.78
|
|
64
|
Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center study.
|
Leuk Lymphoma
|
2004
|
0.78
|
|
65
|
The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
|
Br J Haematol
|
2013
|
0.78
|
|
66
|
Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.
|
Eur J Pediatr
|
2012
|
0.78
|
|
67
|
Clone-specific secondary aberrations are not detected in neonatal blood spots of children with ETV6-RUNX1-positive leukemia.
|
Haematologica
|
2013
|
0.77
|
|
68
|
Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
69
|
Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study.
|
BMC Gastroenterol
|
2014
|
0.77
|
|
70
|
Aneurysmal bone cyst: a hereditary disease?
|
J Pediatr Orthop B
|
2004
|
0.77
|
|
71
|
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.
|
Haematologica
|
2006
|
0.76
|
|
72
|
Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.
|
Endocr Pathol
|
2003
|
0.76
|
|
73
|
Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas.
|
Cancer Biol Ther
|
2002
|
0.76
|
|
74
|
Multiple endocrine neoplasia syndromes.
|
Wien Klin Wochenschr
|
2002
|
0.75
|
|
75
|
Multiple endocrine neoplasia type 1 (MEN1) in Austria.
|
Wien Klin Wochenschr
|
2002
|
0.75
|
|
76
|
Equal frequency of TEL/AML1+ acute lymphoblastic leukemia in children with and without Down syndrome.
|
Pediatr Hematol Oncol
|
2005
|
0.75
|
|
77
|
Quantitation of the sterol regulatory element-binding protein mRNA in mononuclear blood cells by competitive RT-PCR.
|
Clin Chim Acta
|
2003
|
0.75
|
|
78
|
Low frequency of clonotypic Ig and T-cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease.
|
Br J Haematol
|
2002
|
0.75
|
|
79
|
Highly refractory acute myeloid leukemia.
|
Wien Klin Wochenschr
|
2004
|
0.75
|